Literature DB >> 28615119

Schizophrenia and induced abortions: A national register-based follow-up study among Finnish women born between 1965-1980 with schizophrenia or schizoaffective disorder.

Laura Simoila1, Erkki Isometsä2, Mika Gissler3, Jaana Suvisaari4, Eila Sailas5, Erja Halmesmäki6, Nina Lindberg7.   

Abstract

BACKGROUND: The objectives of this study were to investigate, in women with schizophrenia or schizoaffective disorder, the number and incidence of induced abortions (= pregnancy terminations performed by a physician), their demographic characteristics, use of contraceptives, plus indications of and complications related to pregnancy termination.
METHODS: Using the Care Register for Health Care, we identified Finnish women born between the years 1965-1980 who were diagnosed with either schizophrenia or schizoaffective disorder during the follow-up period ending 31.12.2013. For each case, five age- and place-of-birth- matched controls were obtained from the Population Register of Finland. Information about births and induced abortions were obtained from the Medical Birth Register and the Induced Abortion Register.
RESULTS: The number and incidence of induced abortions per 1000 follow-up years did not differ between cases and their controls. However, due to fewer pregnancies, cases exhibited an over 2-fold increased risk of pregnancy termination (RR 2.28; 95% CI 2.20-2.36). Cases were younger, were more often without a partner at the time of induced abortion, and their pregnancies resulted more often from a lack of contraception. Among cases, the indication for pregnancy termination was more often mother-to-be's medical condition. Induced abortions after 12weeks gestation were more common among cases. However, cases had no more complications related to termination.
CONCLUSIONS: The incidence of induced abortions among Finnish women with schizophrenia or schizoaffective disorder is similar to the general population, but their risk per pregnancy over two-fold. They need effective, affordable family planning services and long-term premeditated contraception.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Induced abortion; Schizoaffective disorder; Schizophrenia; Women

Mesh:

Year:  2017        PMID: 28615119     DOI: 10.1016/j.schres.2017.05.039

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  5 in total

1.  Sexual health promotion in people with severe mental illness: the RESPECT feasibility RCT.

Authors:  Elizabeth Hughes; Natasha Mitchell; Samantha Gascoyne; Thirimon Moe-Byrne; Amanda Edmondson; Elizabeth Coleman; Lottie Millett; Shehzad Ali; Ceri Dare; Catherine Hewitt; Sonia Johnson; Carrie Llewellyn; Catherine Mercer; Fiona Nolan; Charlotte Walker; Judith Watson
Journal:  Health Technol Assess       Date:  2019-12       Impact factor: 4.014

2.  Schizophrenia and pregnancy: a national register-based follow-up study among Finnish women born between 1965 and 1980.

Authors:  Laura Simoila; Erkki Isometsä; Mika Gissler; Jaana Suvisaari; Erja Halmesmäki; Nina Lindberg
Journal:  Arch Womens Ment Health       Date:  2019-02-14       Impact factor: 3.633

3.  Pregnancy, delivery and neonatal complications in women with schizophrenia: a national population-based cohort study.

Authors:  Cyprien Fabre; Vanessa Pauly; Karine Baumstarck; Damien Etchecopar-Etchart; Veronica Orleans; Pierre-Michel Llorca; Julie Blanc; Christophe Lancon; Pascal Auquier; Laurent Boyer; Guillaume Fond
Journal:  Lancet Reg Health Eur       Date:  2021-09-07

4.  Severe mental illness and pregnancy outcomes in Australia. A population-based study of 595 792 singleton births 2009-2016.

Authors:  Kristina Edvardsson; Elizabeth Hughes; Beverley Copnell; Ingrid Mogren; Don Vicendese; Richard Gray
Journal:  PLoS One       Date:  2022-02-28       Impact factor: 3.240

5.  The RESPECT study: a feasibility randomised controlled trial of a sexual health promotion intervention for people with serious mental illness in community mental health services in the UK.

Authors:  Elizabeth Hughes; Natasha Mitchell; Samantha Gascoyne; Thirimon Moe-Byrne; Amanda Edmondson; Elizabeth Coleman; Lottie Millett; Shehzad Ali; Francine Cournos; Ceri Dare; Catherine Hewitt; Sonia Johnson; Harminder Dosanjh Kaur; Karen McKinnon; Catherine Mercer; Fiona Nolan; Charlotte Walker; Milton Wainberg; Judith Watson
Journal:  BMC Public Health       Date:  2020-11-17       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.